Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP218027.RAhMlxFyjQLNGdCa1retgWI7GE-Gb6S9GDoG1uyOz-1lA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP218027.RAhMlxFyjQLNGdCa1retgWI7GE-Gb6S9GDoG1uyOz-1lA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP218027.RAhMlxFyjQLNGdCa1retgWI7GE-Gb6S9GDoG1uyOz-1lA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP218027.RAhMlxFyjQLNGdCa1retgWI7GE-Gb6S9GDoG1uyOz-1lA130_provenance.
- NP218027.RAhMlxFyjQLNGdCa1retgWI7GE-Gb6S9GDoG1uyOz-1lA130_assertion description "[Elevated peripheral blood (PB) levels of synoviolin were associated with nonresponse to infliximab treatment/of synoviolin by IL-lbeta and TNFalpha may contribute to prolonged survival of immune cells and rheumatoid arthritis chronicity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP218027.RAhMlxFyjQLNGdCa1retgWI7GE-Gb6S9GDoG1uyOz-1lA130_provenance.
- NP218027.RAhMlxFyjQLNGdCa1retgWI7GE-Gb6S9GDoG1uyOz-1lA130_assertion evidence source_evidence_literature NP218027.RAhMlxFyjQLNGdCa1retgWI7GE-Gb6S9GDoG1uyOz-1lA130_provenance.
- NP218027.RAhMlxFyjQLNGdCa1retgWI7GE-Gb6S9GDoG1uyOz-1lA130_assertion SIO_000772 16802346 NP218027.RAhMlxFyjQLNGdCa1retgWI7GE-Gb6S9GDoG1uyOz-1lA130_provenance.
- NP218027.RAhMlxFyjQLNGdCa1retgWI7GE-Gb6S9GDoG1uyOz-1lA130_assertion wasDerivedFrom lhgdn-20090331 NP218027.RAhMlxFyjQLNGdCa1retgWI7GE-Gb6S9GDoG1uyOz-1lA130_provenance.
- NP218027.RAhMlxFyjQLNGdCa1retgWI7GE-Gb6S9GDoG1uyOz-1lA130_assertion wasGeneratedBy ECO_0000203 NP218027.RAhMlxFyjQLNGdCa1retgWI7GE-Gb6S9GDoG1uyOz-1lA130_provenance.
- lhgdn-20090331 importedOn "2009-03-31" NP218027.RAhMlxFyjQLNGdCa1retgWI7GE-Gb6S9GDoG1uyOz-1lA130_provenance.